Ajanta Pharma Q1 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
3,242.25
120.00 (3.84%)
120.00 (3.84%)Volume18.29 K
Updated: Thu 14 May, 2026 | 15:29:46
NSE
3,259.20136.00 (4.35%)
136.00 (4.35%)Volume3.28 L
Updated: Thu 14 May, 2026 | 15:49:22
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Ajanta Pharma Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 967.44 | 1,133.60 | 5.96% | 848.54 | 14.01% |
| Depreciation/ Amortization | 41.29 | 45.37 | 3.80% | 33.97 | 21.55% |
| Operating Income | 335.21 | 288.04 | 30.24% | 296.38 | 13.10% |
| Net Income | 255.34 | 266.70 | 13.35% | 245.77 | 3.89% |
| Other Operating Expenses Total | 347.37 | 442.70 | 12.03% | 262.94 | 32.11% |
| Net Income Before Taxes | 331.13 | 347.11 | 22.91% | 322.12 | 2.80% |
| Total Revenue | 1,302.65 | 1,421.64 | 11.30% | 1,144.92 | 13.78% |
| Selling/ General/ Admin Expenses Total | 302.90 | 340.72 | 8.26% | 283.78 | 6.74% |
| Diluted Normalized EPS | 20.43 | 21.34 | 13.27% | 19.53 | 4.61% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.